108
Views
16
CrossRef citations to date
0
Altmetric
Review

Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis

&
Pages 1047-1058 | Published online: 08 Mar 2016

References

  • MyasoedovaECrowsonCSKremersHMTherneauTMGabrielSEIs the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955–2007Arthritis Rheum20106261576158220191579
  • CrowsonCSMattesonELMyasoedovaEThe lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseasesArthritis Rheum201163363363921360492
  • ScottDLWolfeFHuizingaTWRheumatoid arthritisLancet201037697461094110820870100
  • van der KooijSMde Vries-BouwstraJKGoekoop-RuitermanYPPatient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritisArthritis Rheum200961141219116965
  • VoskuylAEThe heart and cardiovascular manifestations in rheumatoid arthritisRheumatology200645Suppl 4iv4iv716980723
  • Vliet VlielandTPZwindermanAHBreedveldFCHazesJMMeasurement of morning stiffness in rheumatoid arthritis clinical trialsJ Clin Epidemiol19975077577639253385
  • PhillipsSDowLImpact of impaired morning function on quality of life in rheumatoid arthritis: results of an exploratory patient surveyInt J Clin Rheumatol201276597606
  • ArnettFCEdworthySMBlochDAThe American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritisArthritis Rheum19883133153243358796
  • AletahaDNeogiTSilmanAJ2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeArthritis Rheum20106292569258120872595
  • KaarelaKKauppiJKauppiMThe 2010 ACR/EULAR classification criteria for rheumatoid arthritis in the Heinola inception cohort – diagnoses confirmed by long-term follow-upClin Rheumatol201231354755122052585
  • BoersMButtgereitFSaagKWhat is the relationship between morning symptoms and measures of disease activity in patients with rheumatoid arthritis?Arthritis Care Res Epub 2015 Mar 25
  • TuominenRTuominenSMottonenTHow much is a reduction in morning stiffness worth to patients with rheumatoid arthritis?Scand J Rheumatol Suppl2011125121621529305
  • HallsSDuresEKirwanJStiffness is more than just duration and severity: a qualitative exploration in people with rheumatoid arthritisRheumatology201554461562225231178
  • MeuschURossolMBaerwaldCHauschildtSWagnerUOutside-to-inside signaling through transmembrane tumor necrosis factor reverses pathologic interleukin-1beta production and deficient apoptosis of rheumatoid arthritis monocytesArthritis Rheum20096092612262119714631
  • RossolMKrausSPiererMBaerwaldCWagnerUThe CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell populationArthritis Rheum201264367167722006178
  • KrasseltMBaerwaldCWagnerURossolMCD56+ monocytes have a dysregulated cytokine response to lipopolysaccharide and accumulate in rheumatoid arthritis and immunosenescenceArthritis Res Ther2013155R13924286519
  • MeuschUKlingnerMBaerwaldCRossolMWagnerUDeficient spontaneous in vitro apoptosis and increased tmTNF reverse signaling-induced apoptosis of monocytes predict suboptimal therapeutic response of rheumatoid arthritis to TNF inhibitionArthritis Res Ther2013156R21924354986
  • MeuschUKrasseltMRossolMBaerwaldCKlingnerMWagnerUIn vitro response pattern of monocytes after tmTNF reverse signaling predicts response to anti-TNF therapy in rheumatoid arthritisJ Transl Med20151325626251236
  • ArvidsonNGGudbjornssonBElfmanLRydenACTottermanTHHallgrenRCircadian rhythm of serum interleukin-6 in rheumatoid arthritisAnn Rheum Dis19945385215247944637
  • CutoloMVillaggioBOtsaKAakreOSulliASerioloBAltered circadian rhythms in rheumatoid arthritis patients play a role in the disease’s symptomsAutoimmun Rev20054849750216214085
  • KhuranaRBerneySMClinical aspects of rheumatoid arthritisPathophysiology200512315316516125918
  • StraubRHCutoloMCircadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic managementArthritis Rheum200756239940817265475
  • ArvidsonNGGudbjornssonBLarssonAHallgrenRThe timing of glucocorticoid administration in rheumatoid arthritisAnn Rheum Dis199756127319059137
  • SpiesCMStraubRHCutoloMButtgereitFCircadian rhythms in rheumatology – a glucocorticoid perspectiveArthritis Res Ther201416Suppl 2S325608777
  • StraubRHPaimelaLPeltomaaRScholmerichJLeirisalo-RepoMInadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritisArthritis Rheum200246365466211920401
  • KirwanJRHickeySHHallgrenRThe effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritisArthritis Rheum20065451415142116645969
  • KirwanJRTargeting the time of day for glucocorticoid delivery in rheumatoid arthritisInt J Clin Rheum201163273279
  • NicholsTNugentCATylerFHDiurnal variation in suppression of adrenal function by glucocorticoidsJ Clin Endocrinol Metab19652534334914264259
  • KlinefelterHFWinkenwerderWLBledsoeTSingle daily dose prednisone therapyJAMA19792412527212723221687
  • GrantSDForshamPHDiRaimondoVCSuppression of 17- hydroxycorticosteroids in plasma and urine by single and divided doses of triamcinoloneN Engl J Med196527321111511185842684
  • JasaniMKDiverMJBellAMDalakosTGBuchananWWSome clinical observations on the diurnal rhythm of plasma cortisol (11-OHCS) in patients with rheumatoid arthritis treated with oral corticosteroid drugsCurr Med Res Opin1974273733864476271
  • AlmawiWYMelemedjianOKMolecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptorJ Leukoc Biol200271191511781376
  • CoutinhoAEChapmanKEThe anti-inflammatory and immunosup-pressive effects of glucocorticoids, recent developments and mechanistic insightsMol Cell Endocrinol2011335121320398732
  • ButtgereitFScheffoldARapid glucocorticoid effects on immune cellsSteroids200267652953411960631
  • KrasseltMBaerwaldCThe current relevance and use of prednisone in rheumatoid arthritisExpert Rev Clin Immunol201410555757124717015
  • ButtgereitFDoeringGSchaefflerAEfficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trialLancet2008371960820521418207016
  • DerendorfHRuebsamenKClarkeLSchaefflerAKirwanJRPharmacokinetics of modified-release prednisone tablets in healthy subjects and patients with rheumatoid arthritisJ Clin Pharmacol201353332633323444285
  • ButtgereitFMehtaDKirwanJLow-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)Ann Rheum Dis201372220421022562974
  • ButtgereitFDoeringGSchaefflerATargeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritisAnn Rheum Dis20106971275128020542963
  • CutoloMIaccarinoLDoriaAGovoniMSulliAMarcassaCEfficacy of the switch to modified-release prednisone in rheumatoid arthritis patients treated with standard glucocorticoidsClin Exp Rheumatol201331449850523415134
  • AltenRDoringGCutoloMHypothalamus-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with nighttime-release prednisoneJ Rheumatol201037102025203120682671
  • HoesJNJacobsJWVerstappenSMBijlsmaJWVan der HeijdenGJAdverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysisAnn Rheum Dis200968121833183819066177
  • Da SilvaJAJacobsJWKirwanJRSafety of low dose gluco-corticoid treatment in rheumatoid arthritis: published evidence and prospective trial dataAnn Rheum Dis200665328529316107513
  • MalyshevaOAWahleMWagnerULow-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugsJ Rheumatol200835697998518412314
  • BakkerMFJacobsJWWelsingPMLow-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trialAnn Intern Med2012156532933922393128
  • MontecuccoCTodoertiMSakellariouGScireCACaporaliRLow-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis: results of a 12-month open-label randomised studyArthritis Res Ther2012143R11222584017
  • AltenRGrahnAHoltRJRicePButtgereitFDelayed-release prednisone improves fatigue and health-related quality of life: findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritisRMD Open201511e00013426535146
  • RiefWMillsPJAncoli-IsraelSZieglerMGPungMADimsdaleJEOvernight changes of immune parameters and catecholamines are associated with mood and stressPsychosom Med201072875576220841563
  • RohlederNAringerMBoentertMRole of interleukin-6 in stress, sleep, and fatigueAnn N Y Acad Sci20121261889622823398
  • FragiadakiKTektonidouMGKonstaMChrousosGPSfikakisPPSleep disturbances and interleukin 6 receptor inhibition in rheumatoid arthritisJ Rheumatol2012391606222133618
  • BirnbaumHPikeCKaufmanRMarynchenkoMKidoleziYCifaldiMSocietal cost of rheumatoid arthritis patients in the USCurr Med Res Opin2010261779019908947
  • HuscherDMittendorfTvon HinuberUEvolution of cost structures in rheumatoid arthritis over the past decadeAnn Rheum Dis201574473874524406543
  • DunlopWIqbalIKhanIOuwensMHeronLCost-effectiveness of modified-release prednisone in the treatment of moderate to severe rheumatoid arthritis with morning stiffness based on directly elicited public preference valuesClinicoecon Outcomes Res2013555556424204166
  • BoersMButtgereitFA simple model that suggests possible cost savings when modified-release prednisone 5 mg/day is added to current treatment in patients with active rheumatoid arthritisRheumatology20135281435143723584366
  • ConnDLIs the availability of delayed release prednisone an important clinical advance?Arthritis Care Res Epub 2015 Sep 28
  • CurtisJRChastekBBeckerLCost and effectiveness of biologics for rheumatoid arthritis in a commercially insured populationJ Manag Care Spec Pharm201521431832925803765
  • AltenRHoltRGrahnAMorning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisoneScand J Rheumatol201544535435826114379
  • CutoloMStraubRHButtgereitFCircadian rhythms of nocturnal hormones in rheumatoid arthritis: translation from bench to bedsideAnn Rheum Dis200867790590818556443